YL-109
YL-109 is a novel small molecule compound with demonstrated anticancer activity. It effectively suppresses the proliferation and invasive capacity of breast cancer cells in both in vitro and in vivo models, making it a valuable research tool for oncology and metastasis studies.
Product Specifications
CAS Number
36341-25-0
Product Name Alternative
CHIP, breast, AhR, antitumor, ArylHydrocarbonReceptor, aryl, Aryl Hydrocarbon Receptor, cancer, carboxyl, Hsp70-interacting, hydrocarbon, AhR, Inhibitor, inhibit, invasiveness, YL 109, YL109, YL-109, protein, terminus
Field of Research
Immunology & Inflammation, Metabolism Research
Purity
≥95% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2.5 mg/mL (9.72 mM) ; DMSO:55 mg/mL (213.75 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
COc1cc (ccc1O) -c1nc2ccccc2s1
Molecular Formula
C14H11NO2S
Molecular Weight
257.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
cAP-1224 1 Frozen Vial
CHO-K1/HEK293 Cells Stable expressing GPCR protein GPRC5C (Protein accession # NM_018653)
Sign In for Pricing
View Details MBS1209844-01 0.02 mg (E-Coli)
Recombinant Arthrobacter chlorophenolicus Deoxycytidine triphosphate deaminase (dcd)
Sign In for Pricing
View Details MBS1209844-02 0.1 mg (E-Coli)
Recombinant Arthrobacter chlorophenolicus Deoxycytidine triphosphate deaminase (dcd)
Sign In for Pricing
View Details MBS1209844-03 0.02 mg (Yeast)
Recombinant Arthrobacter chlorophenolicus Deoxycytidine triphosphate deaminase (dcd)
Sign In for Pricing
View Details